A longitudinal nutritional study has been launched in parallel in three countries (United Kingdom, Italy and France) with the aim to provide insight into the impact on Human health of a long-term diet (6 months) with milk kefir, a traditional, widely consumed fermented food with high microbial diversity (around ten species). This study is targeting healthy adults and adults suffering from metabolic syndrome to better focus and health biomarkers and establish if consumption leads to improve clinical outcomes in this cohort.
Several plant-based fermented food prototypes (from vegetables, olives, pulses, cereals or apple pomace) were studied with the objective to collect their natural microbial resources and to characterize the genomic content for understanding their potential of metabolic interaction during fermentation. The data obtained was instrumental to perform consortia-level genome-scale modelling for the design of simplified consortia adapted to each food product.
Meanwhile, the first version of the open Food Microbiome database (FMD) was released with enhanced ontology and functional profiles, allowing the scientific community to get access to the widest metagenomic toolkit for food products including 2,533 metagenomes and thousands of metagenome-assembled genomes (MAGs) from food-born microbial strains.
Finally, six living-labs were formed across EU countries (Estonia, Germany/Austria, France, Ireland, Italy, Spain) to set-up activities for a multi-actor co-creation pathway around the fermented food prototypes studied. The phase 1 of these living-labs (sharing the vision) has been carried out around several consumer focus groups and then with the construction of around 30 multi-stakeholder sessions chosen from the stakeholders’ networks assembled during the first stage of the project. To broaden this vision, a market assessment was also conducted focusing on innovations in beverages and meat substitutes across five EU countries.